NewsFeed Voices Science Insight Innovation
November, 2025
November 2025
M T W T F S S
 12
3456789
10111213141516
17181920212223
24252627282930
Divyaswathi Citla Sridhar: We Counsel Patients With Obesity About VTE Risk, But What Does Real-World Data Actually Show?
Divyaswathi Citla Sridhar/LinkedIn
Nov 10, 2025, 12:28

Divyaswathi Citla Sridhar: We Counsel Patients With Obesity About VTE Risk, But What Does Real-World Data Actually Show?

Divyaswathi Citla Sridhar, a pediatric hematologist and oncologist at Arkansas Children’s Hospital, shared a post on LinkedIn:

“We counsel patients with obesity about VTE risk—but what does real-world data actually show?

Our new study published in RPTH Journal analyzed >4 million females prescribed hormonal therapy and found:

• Higher VTE rates with several ethinyl-estradiol–containing therapies in obese users
• No significant VTE increase with progesterone-only therapy

Full article.

Title: Venous thromboembolism in obese hormonal contraceptive users: a large national database study

Authors: Divyaswathi Citla-Sridhar, Madhvi Rajpurkar, Lakshmi Srivaths, Bethany Samuelson Bannow, Rachel P. Rosovsky, Nancy Sokkary.

Divyaswathi Citla Sridhar: We Counsel Patients With Obesity About VTE Risk, But What Does Real-World Data Actually Show?

Grateful to work with a fantastic group of collaborators: Madhvi Rajpurkar Lakshmi Srivaths Bethany Samuelson Bannow Rachel Rosovsky Nancy Sokkary & Foundation for Women & Girls With Blood Disorders.”

Learn more with Hemostasis Today.

Bethany Samuelson Bannow Divyaswathi Citla-Sridhar Health Hematology Hemostasis Hemostasis Today Lakshmi Srivaths Madhvi Rajpurkar Medicine Nancy Sokkary Rachel P. Rosovsky RPTH Journal venous thromboembolism
NewsFeed